menu search

Aligos therapeutics announces research collaboration and development agreement with xiamen amoytop biotech co. ltd. for use of aligos’ oligonucleotide platform for the treatment of liver diseases

SOUTH SAN FRANCISCO, Calif., May 12, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical s...

May 12, 2023, 9:05 pm


Search within

Pages Search Results: